# Axogen, Inc.: filings

AXGN · Nasdaq · CIK 805928 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/axgn.md) · [Financials](/companies/axgn/financials.md) · [Filings](/companies/axgn/filings.md) · [Insiders](/companies/axgn/insiders.md)

## Reports and events: 299 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 600, 8-K 184, 10-Q 53, 3 53, 144 48, SC 13G/A 34, 4/A 30, SC 13G 20, 10-K 18, CORRESP 16, DEF 14A 16, 424B5 15, S-8 15, CT ORDER 12, S-8 POS 11, EFFECT 9, SCHEDULE 13G/A 9, UPLOAD 9, 8-K/A 8, 3/A 7, S-1/A 6, SC 13D 6, 10-K/A 4, ARS 4, DEFA14A 4, PRE 14A 4, S-3 4, POS AM 3, S-3ASR 3, 424B3 2, 5 2, S-4/A 2, SC 13D/A 2, SCHEDULE 13G 2, 10-Q/A 1, 424B2 1, 424B4 1, 425 1, 5/A 1, 8-A12B 1, CERTNAS 1, D 1, NT 10-Q 1, POSASR 1, POS EX 1, S-1 1, S-3/A 1, S-3MEF 1, S-4 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-01 | 17:25 ET | [8-K](/filings/0000805928-26-000104.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000805928-26-000104 |
| 2026-09-10 | 16:55 ET | [8-K/A](/filings/0001628280-26-061393.md) | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-26-061393 |
| 2026-09-10 | 06:02 ET | [8-K](/filings/0001628280-26-061208.md) | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001628280-26-061208 |
| 2026-07-29 | 16:13 ET | [10-Q](/filings/0000805928-26-000094.md) | Quarterly report, period 2026-06-30 | 0000805928-26-000094 |
| 2026-07-29 | 07:11 ET | [8-K](/filings/0000805928-26-000091.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000805928-26-000091 |
| 2026-06-23 | 16:39 ET | [8-K](/filings/0000805928-26-000081.md) | 5.07 Shareholder vote results | 0000805928-26-000081 |
| 2026-04-29 | 16:05 ET | [DEF 14A](/filings/0000805928-26-000057.md) | Proxy statement, period 2025-12-31 | 0000805928-26-000057 |
| 2026-04-28 | 16:04 ET | [10-Q](/filings/0000805928-26-000053.md) | Quarterly report, period 2026-03-31 | 0000805928-26-000053 |
| 2026-04-28 | 07:02 ET | [8-K](/filings/0000805928-26-000051.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000805928-26-000051 |
| 2026-02-24 | 16:24 ET | [10-K](/filings/0000805928-26-000031.md) | Annual report, period 2025-12-31 | 0000805928-26-000031 |
| 2026-02-24 | 07:02 ET | [8-K](/filings/0000805928-26-000028.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000805928-26-000028 |
| 2026-01-23 | 07:01 ET | [8-K](/filings/0000805928-26-000026.md) | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0000805928-26-000026 |
| 2026-01-12 | 07:10 ET | [8-K](/filings/0000805928-26-000004.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000805928-26-000004 |
| 2025-12-05 | 16:11 ET | [8-K](/filings/0000805928-25-000146.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0000805928-25-000146 |
| 2025-12-04 | 20:03 ET | [8-K](/filings/0000805928-25-000140.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0000805928-25-000140 |
| 2025-10-29 | 16:07 ET | [10-Q](/filings/0000805928-25-000130.md) | Quarterly report, period 2025-09-30 | 0000805928-25-000130 |
| 2025-10-29 | 07:03 ET | [8-K](/filings/0000805928-25-000128.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000805928-25-000128 |
| 2025-08-25 | 06:41 ET | [8-K](/filings/0000805928-25-000112.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000805928-25-000112 |
| 2025-08-05 | 16:52 ET | [10-Q](/filings/0000805928-25-000107.md) | Quarterly report, period 2025-06-30 | 0000805928-25-000107 |
| 2025-08-05 | 07:02 ET | [8-K](/filings/0000805928-25-000104.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000805928-25-000104 |
| 2025-06-20 | 16:05 ET | [8-K](/filings/0000805928-25-000095.md) | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0000805928-25-000095 |
| 2025-05-08 | 16:38 ET | [10-Q](/filings/0000805928-25-000064.md) | Quarterly report, period 2025-03-31 | 0000805928-25-000064 |
| 2025-05-08 | 07:10 ET | [8-K](/filings/0000805928-25-000062.md) | 2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0000805928-25-000062 |
| 2025-04-30 | 07:07 ET | [DEF 14A](/filings/0000805928-25-000059.md) | Proxy statement, period 2025-06-18 | 0000805928-25-000059 |
| 2025-04-07 | 07:08 ET | [8-K](/filings/0000805928-25-000053.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000805928-25-000053 |
| 2025-03-04 | 07:06 ET | [8-K](/filings/0000805928-25-000024.md) | 7.01 Regulation FD disclosure | 0000805928-25-000024 |
| 2025-02-26 | 16:09 ET | [10-K](/filings/0000805928-25-000017.md) | Annual report, period 2024-12-31 | 0000805928-25-000017 |
| 2025-02-25 | 07:09 ET | [8-K](/filings/0000805928-25-000010.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure | 0000805928-25-000010 |
| 2025-01-10 | 08:01 ET | [8-K](/filings/0000805928-25-000006.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000805928-25-000006 |
| 2024-11-07 | 16:12 ET | [10-Q](/filings/0000805928-24-000137.md) | Quarterly report, period 2024-09-30 | 0000805928-24-000137 |
| 2024-11-07 | 07:08 ET | [8-K](/filings/0000805928-24-000135.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000805928-24-000135 |
| 2024-09-06 | 07:09 ET | [8-K](/filings/0000805928-24-000127.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000805928-24-000127 |
| 2024-08-09 | 16:05 ET | [8-K](/filings/0001193125-24-197821.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-24-197821 |
| 2024-08-08 | 16:10 ET | [10-Q](/filings/0000805928-24-000111.md) | Quarterly report, period 2024-06-30 | 0000805928-24-000111 |
| 2024-08-08 | 07:14 ET | [8-K](/filings/0000805928-24-000107.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000805928-24-000107 |
| 2024-06-10 | 21:15 ET | [8-K/A](/filings/0001193125-24-157679.md) | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001193125-24-157679 |
| 2024-06-07 | 16:31 ET | [8-K](/filings/0000805928-24-000079.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0000805928-24-000079 |
| 2024-05-02 | 16:07 ET | [10-Q](/filings/0000805928-24-000072.md) | Quarterly report, period 2024-03-31 | 0000805928-24-000072 |
| 2024-05-02 | 07:00 ET | [8-K](/filings/0000805928-24-000070.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000805928-24-000070 |
| 2024-04-24 | 07:32 ET | [DEF 14A](/filings/0000805928-24-000066.md) | Proxy statement, period 2024-06-05 | 0000805928-24-000066 |
| 2024-03-08 | 16:38 ET | [8-K](/filings/0000805928-24-000037.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0000805928-24-000037 |
| 2024-03-05 | 16:29 ET | [8-K](/filings/0000805928-24-000029.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000805928-24-000029 |
| 2024-03-05 | 16:27 ET | [10-K](/filings/0000805928-24-000028.md) | Annual report, period 2023-12-31 | 0000805928-24-000028 |
| 2024-03-05 | 07:16 ET | [8-K](/filings/0000805928-24-000025.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000805928-24-000025 |
| 2024-01-08 | 07:05 ET | [8-K](/filings/0000805928-24-000013.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000805928-24-000013 |
| 2024-01-05 | 17:21 ET | [8-K/A](/filings/0000805928-24-000011.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0000805928-24-000011 |
| 2024-01-04 | 16:56 ET | [8-K](/filings/0000805928-24-000005.md) | 2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000805928-24-000005 |
| 2023-12-26 | 16:21 ET | [8-K](/filings/0000805928-23-000156.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000805928-23-000156 |
| 2023-12-06 | 07:15 ET | [8-K](/filings/0000805928-23-000151.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000805928-23-000151 |
| 2023-11-07 | 16:03 ET | [10-Q](/filings/0000805928-23-000148.md) | Quarterly report, period 2023-09-30 | 0000805928-23-000148 |

Page 1 of 6. [Older](/companies/axgn/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 28, 2026, 07:05 ET. No prices; not investment advice.